Found 73 matching trials
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants PHASE4 This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa⢠(DTPa-HBV-IPV/Hib) Vaccine PHASE3 This study evaluates the immunogenicity and safety of Infanrix hexa⢠(DTPa-...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine PHASE4 The purpose of this study is to evaluate the long-term antibody persistence...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. PHASE2 This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety of Havrix⢠Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months PHASE3 This is a study to evaluate the immune response and safety of GSK Biologica...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerixâ˘-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix⢠Hexa During Infancy PHASE4 The purpose of this study is to assess the long-term persistence of immunit...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine PHASE2 The purpose of this booster study is to evaluate, in subjects primed in the...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age PHASE2 This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine. PHASE3 This study will evaluate the safety, reactogenicity and immunogenicity of a...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects PHASE3 Infection with human papillomavirus (HPV) has been clearly established as t...
Show More Location
GSK Investigational Site
Learn More & Join Trial